Deals relating to China’s socioeconomic impact decreased significantly in the pharma industry in H2 2021
During second half of 2021, deals relating to China's socioeconomic impact accounted for 10.9% of all deals taking place…
By
Emil Filipov
All Articles
Cloud-related deals in the pharma industry increased in H1 2021
In the first six months of 2021, the total number of announced deals in the pharmaceutical sector increased by…
By